RNA-binding protein IGF2BP2 suppresses metastasis of clear cell renal cell carcinoma by enhancing CKB mRNA stability

Junwu Ren1, Bo Huang2, Wei Li3

  • 1College of Pharmacy, Chongqing Medical University, Chongqing 400016, PR China.

Translational Oncology
|February 11, 2024
PubMed

Insights

Insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2) suppresses clear cell renal cell carcinoma (ccRCC) metastasis. This RNA binding protein enhances Creatine Kinase B (CKB) expression, offering a potential therapeutic target for kidney cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Clear cell renal cell carcinoma (ccRCC) is an aggressive kidney cancer with poor prognosis.
  • RNA binding proteins (RBPs) are critical in gene regulation and implicated in cancer development.
  • RBPs represent potential therapeutic targets for ccRCC.

Purpose of the Study:

  • To identify and validate novel RNA binding proteins (RBPs) as therapeutic targets for ccRCC.
  • To investigate the role of insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2) in ccRCC progression.
  • To elucidate the molecular mechanism by which IGF2BP2 affects ccRCC metastasis.

Main Methods:

  • Screening and validation of RBPs in ccRCC tissues and cell lines.
  • In vitro and in vivo functional assays to assess ccRCC cell migration and invasion.
  • RIP-seq and actinomycin D experiments to determine mRNA targets and stability.
  • Analysis of IGF2BP2 and Creatine Kinase B (CKB) expression levels.

Main Results:

  • IGF2BP2 was found to be downregulated in ccRCC tissues and cell lines.
  • IGF2BP2 significantly suppressed ccRCC cell migration and invasion both in vitro and in vivo.
  • IGF2BP2 enhances Creatine Kinase B (CKB) expression by increasing CKB mRNA stability.
  • RIP-seq identified CKB mRNA as a target of IGF2BP2.

Conclusions:

  • IGF2BP2 acts as a metastasis suppressor in ccRCC.
  • IGF2BP2 inhibits ccRCC metastasis by enhancing CKB expression.
  • IGF2BP2 is a potential therapeutic target for ccRCC treatment.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K